Clinical Trial Update: Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).

View source ↗

Summary

A global patient registry is being established to monitor long-term safety and effectiveness of Increlex (mecasermin) in children and adolescents with severe pr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insulin-like Growth Factor Deficiency

Drugs mentioned

• INCRELEX (Mecasermin)

Snippet

Sponsor: Esteve Pharmaceuticals, S.A. | Conditions: IGF1 Deficiency | Status: RECRUITING